Insider Transactions Reported by 16 Insiders of uniQure N.V.

Symbol
QURE on Nasdaq
Location
Amsterdam

Insiders trading volume in the past year

uniQure N.V. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Matthew C. Kapusta CEO, Managing Director, Director $5,985,561 -$7,446,564 -55% 04 Mar 2026
Kylie O'Keefe Chief Customer & Strat Officer $3,201,120 04 Mar 2026
Christian Klemt Chief Financial Officer $2,052,823 -$501,871 -20% 04 Mar 2026
Walid Abi-Saab Chief Medical Officer $1,718,401 -$44,244 -2.5% 04 Mar 2026
Jeannette Potts Chief Legal Officer $1,254,655 -$186,968 -13% 04 Mar 2026
Ricardo Dolmetsch President, R&D $1,218,994 18 Sep 2023
Robert Gut Director $811,460 -$1,535,569 -65% 12 Jan 2026
Alexander Edward Kuta III Executive VP, Operations $674,242 07 Mar 2023
Jack Kaye Director $557,575 -$1,382,355 -71% 09 Jan 2026
PIERRE CALOZ Chief Operating Officer $556,551 17 Jun 2024
Madhavan Balachandran Director $544,721 -$30,518 -5.3% 20 Jun 2025
Jeremy P. Springhorn Director $544,678 -$30,518 -5.3% 20 Jun 2025
David D. Meek Director $494,045 -$30,518 -5.8% 20 Jun 2025
LEONARD E. POST Director $432,589 -$30,518 -6.6% 20 Jun 2025
Rachelle Suzanne Jacques Director $409,599 -$30,518 -6.9% 20 Jun 2025
Paula Soteropoulos Director $103,843 13 Jun 2024

Recent Insider Transactions by Companies or Individuals for uniQure N.V.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.